#15: FastFun: DUSA Pharmaceuticals Announces $11 Million in Private Placement of Common Stock and Warrants to Institutional Investors DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA), a dermatology company that is... |
November 27, 2007 09:22:52 PM |
#14: NewsBot: DUSA News DUSA Pharmaceuticals Signs Merger Agreement To Acquire Sirius Laboratories WILMINGTON, Mass.--(BUSINESS WIRE)--Jan. 3, 2006-- Strengthens DUSA's... |
January 3, 2006 12:50:00 AM |
#13: NewsBot: DUSA News DUSA Pharmaceuticals Reports Third Quarter Corporate Highlights and Financial Results WILMINGTON, Mass.--(BUSINESS WIRE)--Nov. 4, 2005--DUSA Pharmaceuticals, Inc.... |
November 4, 2005 01:00:00 AM |
#12: NewsBot: DUSA News DUSA Pharmaceuticals, Inc. to Host Third Quarter 2005 Corporate Highlights and Financial Results Conference Call WILMINGTON, Mass.--(BUSINESS WIRE)--Nov. 1, 2005--DUSA Pharmaceuticals, Inc.... |
November 1, 2005 02:00:00 AM |
#11: NewsBot: DUSA News DUSA Pharmaceuticals to Present at CIBC World Markets 16th Annual Healthcare Conference in New York WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 31, 2005--DUSA Pharmaceuticals, Inc.... |
October 31, 2005 02:00:00 AM |
#10: NewsBot: DUSA News CORRECTING and REPLACING DUSA Pharmaceuticals, Inc.: Independent Investigator Reports Complete Clearing Of Recalcitrant Inflammatory Acne Using Levulan(R) Photodynamic Therapy With Long Pulse Dye Laser WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 28, 2005--Please replace the release with... |
October 28, 2005 10:52:00 AM |
#9: NewsBot: DUSA News DUSA Pharmaceuticals to Present at The Rodman & Renshaw Techvest 7th Annual Healthcare Conference in New York WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 27, 2005--DUSA Pharmaceuticals, Inc.... |
October 27, 2005 01:00:00 AM |
#8: NewsBot: DUSA News DUSA Pharmaceuticals, Inc.: Positive Independent Study Reports that Levulan'R' Photodynamic Therapy Using Intense Pulsed Light 'IPL' Significantly Improves Photodamaged Skin Compared to IPL Alone WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 20, 2005-- Groundbreaking Study in... |
October 20, 2005 01:00:00 AM |
#7: NewsBot: DUSA News DUSA Pharmaceuticals, Inc. to Present at UBS Global Life Sciences Conference WILMINGTON, Mass.--(BUSINESS WIRE)--Sept. 21, 2005--DUSA Pharmaceuticals, Inc.... |
September 21, 2005 01:00:00 AM |
#6: NewsBot: DUSA News DUSA Pharmaceuticals Reports Second Quarter Financial Results WILMINGTON, Mass.--(BUSINESS WIRE)--Aug. 3, 2005-- Company To Streamline... |
August 3, 2005 12:00:00 AM |
#5: NewsBot: DUSA News DUSA Pharmaceuticals, Inc. To Host Second Quarter 2005 Corporate Highlights And Financial Results Conference Call WILMINGTON, Mass.--(BUSINESS WIRE)--July 29, 2005--DUSA Pharmaceuticals, Inc.... |
July 29, 2005 01:00:00 AM |
#3: NewsBot: DUSA News Dusa Announces Second Quarter 2005 Levulan'R' Kerastick'R' And BLU-U'R' Sales WILMINGTON, Mass.--(BUSINESS WIRE)--July 14, 2005--DUSA Pharmaceuticals, Inc.... |
July 14, 2005 10:00:00 AM |
#4: NewsBot: DUSA News DUSA Announces Resignation of Officer WILMINGTON, Mass.--(BUSINESS WIRE)--July 14, 2005--DUSA Pharmaceuticals, Inc.... |
July 14, 2005 10:00:00 AM |
#2: NewsBot: DUSA News DUSA Pharmaceuticals, Inc. to Host Conference Call Re Second Quarter 2005 Levulan'R' Kerastick'R' and BLU-U'R' Sales Update WILMINGTON, Mass.--(BUSINESS WIRE)--July 12, 2005--DUSA Pharmaceuticals, Inc.... |
July 12, 2005 01:00:00 AM |
#1: NewsBot: DUSA News DUSA Provides Investor Update WILMINGTON, Mass.--(BUSINESS WIRE)--June 22, 2005--In response to current market... |
June 22, 2005 08:43:00 AM |